The National Agency for Food and Drug Administration and Control has announced the approval of Pfizer-BionTech COVID-19 vaccine for emergency use in Nigeria.

Director-General of the agency, Prof Mojisola Adeyeye, announced this at the agency’s headquarters in Lagos on Friday.

She stated the vaccine, which is only for emergency use, can be stored between -15oC to -25oC equivalent to freezer temperature.

Also Read: Lagos Shuts All COVID-19 Vaccination Centres

The NAFDAC boss also revealed that the agency relied on a more mature regulatory body for its approval, adding that that the agency was at liberty to review its stance since the World Health Organisation had given emergency use listing.

Adeyeye said, “The purpose of the press briefing is to announce that NAFDAC has just approved Pfizer-BionTech vaccines for possible use in Nigeria.

“They were reviewed carefully by the NAFDAC staff COVID-19 vaccine committee to make sure that the science behind the development is well understood and in accord with our world regulatory activities.

“We used different mechanisms to approve the vaccine. We used reliance, meaning that a more mature regulatory agency across the globe, we can use that as a basis for our review.

“We will get the assessment report, know the peculiarity there, then our COVID-19 committee will get to do their job.”